Thermo Fisher Scientific Releases Corporate Social Responsibility Report

Report highlights progress toward environmental, social and governance objectives WALTHAM, Mass.–(BUSINESS WIRE)– Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today released its annual Corporate Social Responsibility (CSR) report. The report highlights the company’s commitment to society and stakeholders providing detailed insight into the company’s CSR progress and environmental, social and governance... Read more

500 Billion Gallons of Water Prevented from Flooding Communities in 2021, Using Xylem Technology

Xylem’s Latest Sustainability Report Tracks Progress in Solving Global Water Challenges Company on pace to achieve net zero carbon emissions. Net GHG emission intensity reduced 12% More than half of Xylem’s 22 major facilities now operating on 100% renewable energy Helped customers reuse more than 285 billion gallons of water in 2021 RYE BROOK, N.Y.–(BUSINESS WIRE)–May... Read more

Xylem Wins for “Net Zero” Leadership at Global Water Awards

RYE BROOK, N.Y.–(BUSINESS WIRE)–May 20, 2022– Global water technology leader Xylem (NYSE:XYL) was named “Net Zero Carbon Champion” at the 2022 Global Water Awards, recognizing the Company’s work to accelerate the decarbonization of the water sector. In addition to its own commitments to achieve net-zero carbon emissions, Xylem is partnering with utilities, businesses and water... Read more

PerkinElmer Expands Genomic Testing Services with Ultrarapid Whole Genome Sequencing

Latest addition to Company’s genomic testing services menu delivers rapid results to physicians that inform clinical management and outcomes for critically ill patients WALTHAM, Mass. – May 16, 2022 – PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced the availability of ultrarapid whole genome sequencing (urWGS) through PerkinElmer Genomics.... Read more

Danaher Joins Bespoke Gene Therapy Consortium (BGTC) for Rare Diseases

Consortium aims to speed the development and delivery of customized or ‘bespoke’ gene therapies WASHINGTON, May 12, 2022 /PRNewswire/ — Danaher Corporation (NYSE: DHR) announced that it has joined the Bespoke Gene Therapy Consortium (BGTC). Launched in October 2021, the BGTC will generate gene therapy resources that the research community can use to streamline gene... Read more

Danaher To Present At Bank Of America Securities Health Care Conference

WASHINGTON, May 4, 2022 /PRNewswire/ — Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Rainer M. Blair, will be presenting at the Bank of America Securities Health Care Conference in Las Vegas, Nevada on Wednesday, May 11, 2022 at 10:00 a.m. PT. The audio will be simultaneously webcast on www.danaher.com.  ABOUT DANAHERDanaher... Read more